20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Methods for treating cone dystrophy with neuronal viability factor, RDCVF2
#4202Compositions and methods for angiogenic therapy utilizing genes encoding ets-1
#4203MODULATION OF SIRP-ALPHA - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR
#4204Methods and compositions for genetic and retinal disease
#4205Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
#4206Matrix protein compositions for induction of apoptosis
#4207Use of Nestafin-1 in the Treatment for Diabetes
#4208PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR
#4209CONTRACEPTIVE METHODS AND COMPOSITIONS RELATED TO PROTEASOMAL INTERFERENCE
#4210Compositions and Methods for Modification of Target Cells and to Their Uses Thereof
#4211Targeted vectors for cancer immunotherapy
#4212Method of treating ischemic injury with follistatin-like 1 polypeptide
#4213Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis
#4214BETA-2-GLYCOPROTEIN 1 IS AN INHIBITOR OF ANGIOGENESIS
#4215Dynamic bio-nanoparticle elements
#4216COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY
#4217COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#4218Delivery system for heparin-binding growth factors
#4219Treatment methods for fibrosis related disorders
#4220USE OF THE PEPTIDE PRO-GLY-THR-CYS-GLU-ILE-CYS-ALA-TYR-ALA-ALA-CYS-THR-GLY-CYS AS A THERAPEUTIC AGENT
#4221Cosmetic use of apolipoprotein D type proteins
#4222KRUPPEL-LIKE FACTORS AND FAT REGULATION
#4223METHOD FOR INHIBITING CELLULAR ACTIVATION BY INSULIN-LIKE GROWTH FACTOR-1
#4224Methods of using enterostatin as inhibitor of angiogenesis
#4225MIA-2 PROTEIN
#4226Modulation of activity of proneurotrophins
#4227Product comprising a combination of milk serum apoproteins and free fatty acids
#4228MAGE3 polypeptides
#4229AMYLOID BETA(1-42) OLIGOMERS, DERIVATIVES THEREOF AND ANTIBODIES THERETO, METHODS OF PREPARATION THEREOF AND USE THEREOF
#4230Deletion of unwanted reply messages in e-mail printing
#4231Process for the production of immunogenic compositions
#4232Antibodies to tumor associated proteins
#4233USE OF A PEPTIDE AS A THERAPEUTIC AGENT
#4234USE OF GLUTEN EXORPHIN C : AS A THERAPEUTIC AGENT
#4235USE OF THE PEPTIDES MAIPPKKNQDK (COW KAPPA CASEIN 106-116) AND/OR YGFQNA (SERORPHIN) AS THERAPEUTIC AGENTS
#4236Method and product for treatment and/or prevention of complications of prematurity
#4237Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
#4238USE OF HEAT SHOCK ACTIVATORS FOR TISSUE REGENERATION
#4239TRIBONECTINS
#4240MECP2E1 gene
#4241Method for inhibiting or reducing dry eye disease by IL-1Ra
#4242Chemorepulsion of cells
#4243THERAPEUTIC USE OF PEPTIDE YGLF AND COMBINATION WITH KVLPVPQ
#4244Manipulation of ovarian primordial follicles
#4245Compositions and methods for preventing or treating cancer
#4246Compositions and methods of treating neoplasia
#4247METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION
#4248Use of Hepatitis B X-Interacting Protein (HBXIP) in Modulation of Apoptosis
#4249Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation
#4250Methods of Treating Various Cancers Using Melanoma Differentiating Associated Protein-7
#4251Peptide-based stat inhibitor
#4252Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange
#4253Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
#4254TARGETED FUSION PROTEINS FOR CANCER THERAPY
#4255Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor
#4256TOPICALLY ACTIVE STEROIDS FOR USE IN RADIATION AND CHEMOTHERAPEUTICS INJURY
#4257Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
#4258PEPTIDE EPITOPES OF APOLIPOPROTEIN B
#4259Therapies for cancer using RLIP76
#4260METHODS OF REDUCING PAPILLOMAVIRUS INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES
#4261METHODS AND COMPOSITIONS FOR THE TREATMENT OF FIBROTIC CONDITIONS AND IMPAIRED LUNG FUNCTION AND TO ENHANCE LYMPHOCYTE PRODUCTION
#4262COMPOSITIONS AND METHODS FOR REGULATING SAS1R
#4263Chimeric DRG11-responsive (DRAGON) polypetides
#4264Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1Ra
#4265Pharmaceutical Composition for Treating Autoimmune, Allergic and Inflammatory Diseases and Delivery Method Thereof
#4266Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof
#4267Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#4268DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS
#4269Treatment of stroke using domain V of perlecan
#4270Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration
#4271HEMATOPOIETIC CELLS THAT EXPRESS MOSC-1
#4272EXTRACELLULAR MATRIX/METASTASIS MODIFIER GENES FOR THE PREVENTION OR INHIBITION OF METASTASIS OR GROWTH OF TUMOR AND FOR CHARACTERIZATION OF TUMOR
#4273Expanding the eukaryotic genetic code
#4274Physiologically active complex comprising protamine and/or salt therefor and an acidic macromolecular substance, and use thereof
#4275Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
#4276Assays and methods using biomarkers
#4277MEANS AND METHODS FOR DIAGNOSING AND TREATING CANCER BASED ON THE FRMD3 GENE
#4278Anti-tumor drug, medicament, composition, and use thereof
#4279Purkinje cell-tropic viral vector
#4280METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF
#4281Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide
#4282Compositions containing an intestinal trefoil peptide and a mucoadhesive
#4283METHODS AND USES THEREOF OF PROSAPOSIN
#4284Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
#4285Peptides and peptide mimetics to treat pathologies associated with eye disease
#4286Alpha-defensins as anthrax immunotherapeutics
#4287Method of treating diabetes
#4288Infarct area perfusion-improving compositions and methods of vascular injury repair
#4289Viral vectors
#4290Method of reducing injury to mammalian cells
#4291Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor
#4292Use of FGF-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation
#4293MEDICAMENTS
#4294Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition
#4295Treatment for age-related macular degeneration and other diseases of the eye
#4296Method of treatment of type-1 diabetes with a humanin analogue
#4297Method for treating cartilage disorders
#4298Biglycan and related therapeutics and methods of use
#4299Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
#4300Methods and compositions for the inhibition of Stat5 in prostate cancer cells
#4301Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#4302COMPOSITION FOR PREVENTING AND/OR TREATING PEPTIC ULCERS
#4303Methods and reagents for vaccination which generate a CD8 T cell immune response
#4304Human skin equivalents expressing exogenous polypeptides
#4305Treatment and/or Prevention of Non-Viral Epithelial Damage
#4306THERAPEUTIC AGENT COMPRISING VASOHIBIN
#4307METHODS INVOLVING LEF-1 REGULATION AND USE OF LEF-1 OR COMPOUNDS ALTERING LEF-1 SIGNALLING FOR TREATING OR PREVENTING DISEASES
#4308Induction of Renal Cells for Treatment of Kidney Disease
#4309Diagnosis and treatment of preeclampsia
#4310Method for preventing and treating cardiovascular diseases with BRCA1
#4311REDUCTION OF POLYALANINE-INDUCED PROTEIN AGGREGATES AND TOXICITY BY UBIQUILIN
#4312Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
#4313Casein complexes
#4314Chaperonin 10 immunosuppression
#4315Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith
#4316Effect of Bri Proteins on Ass Production
#4317Anti-pathogen treatments
#4318Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy
#4319PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES IN DISEASE
#4320SCGB3A2 as a growth factor and anti-apoptotic agent
#4321METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#4322USE OF BIGLYCAN OR ENHANCERS OF BIGLYCAN ACTIVITY IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS
#4323Vault and vault-like carrier molecules
#4324Recombinant lubricin molecules and uses thereof
#4325Preparation of a therapeutic composition
#4326Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells
#4327Use of Nutritional Compositions for Preventing Disorders
#4328Recombinant lubricin molecules and uses thereof
#4329Compositions and methods for the systemic treatment of arthritis
#4330Compositions and methods for the systemic treatment of arthritis
#4331Methods of organ regeneration using Hox11-expressing pluripotent cells
#4332Use of nutritional compositions for preventing disorders
#4333USE OF HEAT SHOCK TO TREAT OCULAR DISEASE
#4334Transgenic non-human animals expressing a truncated activin type II receptor
#4335METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3, AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2
#4336Therapies which act on neuropeptide S receptors
#4337Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
#4338MEDICAL USES
#4339METHOD FOR TREATING KIDNEY DISORDERS
#4340Methods for treating diabetic wounds
#4341Angiogenesis inhibitor comprising meteorin as an active ingredient
#4342Tribonectins
#4343TREATMENT FOR DARK ADAPTATION
#4344Reversible pegylated drugs
#4345ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#4346Methods of inducing IL-10 production
#4347Skin wound healing compositions and methods of use thereof
#4348TARGETED BIOCIDES
#4349TREATMENT OF PAIN
#4350Method for diagnosing and treating bone-related diseases
#4351COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#4352Prevention and treatment of synucleinopathic and amyloidogenic disease
#4353Method Of Diagnosing Pon1-Hdl Associated Lipid Disorders
#4354METHODS FOR THE MODULATION OF BRAIN PROGESTAGEN SIGNALING IN THE PREVENTION AND TREATMENT OF NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES
#4355Antagonists of actriib and uses for increasing red blood cell levels
#4356Antagonists of activin-actriia and uses for increasing red blood cell levels
#4357Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions
#4358COMPOSITIONS AND METHODS FOR INCREASING SERUM ANTIOXIDANT CONCENTRATIONS, DECREASING SERUM TRIGLYCERIDE LEVELS, INHIBITING INSULIN-RECEPTOR SIGNALING ACTIVITY, INCREASING SERUM GHRELIN LEVELS, AND DECREASING SERUM TNF-ALPHA LEVELS
#4359HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
#4360Formulations of peptides and chloroquines for the treatment of pathogenic immune responses in immune mediated diseases
#4361GASP1: a follistatin domain containing protein
#4362Targeting of triacylclycerol synthase gene for tuberculosis treatment
#4363Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel)
#4364METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVOUS SYSTEM SITES
#4365Compositions comprising MG29 nucleic acids, polypeptides, and associated methods of use
#4366Diagnosing, monitoring and treating inflammation
#4367Pathotropic targeted gene delivery system for cancer and other disorders
#4368METHODS AND COMPOSITIONS FOR INHIBITING C-MET DIMERIZATION AND ACTIVATION
#4369Inhibitors of protein phosphatase 1, GADD34 and protein phosphatase 1/GADD34 complex, preparation and uses thereof
#4370Agent for inducing apoptosis comprising MSX1 or a gene encoding the same as an active ingredient
#4371CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#4372DISC-1 pathway activators in the control of neurogenesis
#4373Methods of Binding of Cross-Beta Structures By Chaperones
#4374Nogo, Caspr, F3 NB-3 useful in the treatment of injury and disease to the central nervous system
#4375MODIFIED STAT1 TRANSGENE THAT CONFERS INTERFERON HYPERRESPONSIVENESS, METHODS AND USES THEREFOR
#4376Apolipoprotein A1 mimetics and uses thereof
#4377Methods for promoting wound healing and/or reducing scar formation
#4378Coronin 1 modulators for the treatment of autoimmune and Lymphoproliferative disorders and mycobacterial infections
#4379Antibodies against a peptide epitope of apolipoprotein B
#4380Compositions for mucosal and oral administration comprising hcg fragments
#4381Therapeutic Methods for Neuropathic Pain
#4382Use of Crystallin For The Modulation of Angiogenesis
#4383Endothelin and Endothelin Receptor Agonists in the Treatment of Metabolic Diseases
#4384HSP60, HSP60 peptides and T cell vaccines for immunomodulation
#4385Hybrid-AAV vectors to deliver large gene expression cassette
#4386Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
#4387Materials and methods for FOXP3 tumor suppression
#4388Means and methods for diagnosing and/or treating a subject at risk of developing heart failure
#4389Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation
#4390Polymer conjugates of Box-A of HMGB1 and Box-A variants of HMGB1
#4391Methods and reagents for vaccination which generate a CD8 T cell immune response
#4392METHOD OF MODIFYING GLUCOSE ACTIVITY USING POLYPEPTIDES SELECTIVELY EXPRESSED IN FAT TISSUE
#4393USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#4394USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#4395USES OF HUMAN ZVEN PROTEINS AND POLYNUCLEOTIDES
#4396SRA binding protein
#4397Protection Against Oxidative Damage in Cells
#4398NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#4399Therapeutic Peptide Compositions And Methods Of Making And Using Same
#4400THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2
#4401Methods and compositions for treatment of retinoid-responsive conditions
#4402Dry powder inhaler and system for drug delivery
#4403Dry powder inhaler and system for drug delivery
#4404Dry powder inhaler and system for drug delivery
#4405Methods of inhibiting osteoclast activity
#4406USE OF AN INTERLEUKIN 1 RECEPTOR ANTAGONIST AND/OR PYRROLIDINEDITHIOCARBAMATE FOR THE TREATMENT OR PROPHYLAXIS OF TYPE 2 DIABETES
#4407Muteins of tear lipocalin and methods for obtaining the same
#4408Secreted protein acidic and rich in cysteine (SPARC) as chemotherapeutic sensitizers
#4409Use of histones for therapeutic purposes
#4410Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
#4411MASTER GENE OF ARTERIOGENESIS
#4412R-RAS activity in vascular regulation
#4413Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
#4414Modulators of alpha-synuclein toxicity
#4415USE OF GSK-3 INHIBITORS FOR THE TREATMENT OF PROSTATE CANCER
#4416Repair of the Bone Marrow Vasculature
#4417Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
#4418Use of an active biological substance in abnormal cellular and viral membrane physiologies
#4419Therapeutics to inhibit MLL-menin interaction for treating leukemia
#4420USE OF SECRETED PROTEIN PRODUCTS FOR PREVENTING AND TREATING PANCREATIC DISEASES AND/OR OBESITY AND/OR METABOLIC SYNDROME
#4421C-reactive protein and its use to treat systemic lupus erythematosus and related conditions
#4422Trophic factor combinations for nervous system treatment
#4423Neurotoxic oligomers
#4424Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
#4425PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#4426USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES
#4427Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
#4428Treatment of HIV
#4429Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#4430Methods for improving the structure and function of arterioles
#4431Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
#4432Method of reducing injury to mammalian cells
#4433Use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption
#4434Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
#4435Methods for treating atrial or ventricular arrhythmias
#4436Method of making a molded food item from individual food pieces
#4437Antibodies against a peptide epitope of apolipoprotein B
#4438JAK/STAT pathway inhibitors and uses thereof
#4439Use of repeat sequence protein polymers in personal care compositions
#4440Use of nucleic acids with reduced pressure therapy
#4441Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
#4442Method for treating rheumatoid arthritis using anti-S100A9 antibody
#4443Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
#4444Compositions of active Wnt protein
#4445Therapeutic agent for infections, and treatment method using the same
#4446Over-expression of MPS-1 gene or its gene product(s) results in reduction in size of a variety of malignancies
#4447Use of galectin-7 to promote the re-epithelialization of wounds
#4448Method of treatment for ischemic heart disease
#4449Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#4450Diagnostic and therapeutic uses of gelsolin in renal failure
#4451NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#4452APOPTOSIS METHODS, GENES AND PROTEINS
#4453Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity
#4454Engineered integrin binding peptides
#4455USE OF TLR3 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
#4456Novel peptide involved in energy homeostasis
#4457Controlled release of biological entities
#4458Compositions and Methods for Treating Polyglutamine-Expansion Neurodegenerative Diseases
#4459Method and device for producing shaped meat portions from whole natural meat pieces
#4460Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
#4461Antimicrobial composition
#4462Hsp70 peptide stimulating natural killer (NK) cell activity and uses thereof
#4463DNA vaccines encoding heat shock proteins
#4464OPHTHALMIC COMPOSITION
#4465Methods of Dissolving Beta-Sheet Proteins and Uses Thereof
#4466Treatment of ocular wounds and ulcers
#4467Nutritional compositions
#4468Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
#4469NOVEL APPLICATION OF APELIN
#4470Biomarkers and therapeutics targets for cognitive decline
#4471In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide
#4472Method for regulating production of hemoglobin beta chains
#4473Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death
#4474COMPOSITIONS AND METHODS FOR TREATING ACTIN-MEDIATED MEDICAL CONDITIONS
#4475Agents for preventing and/or treating upper digestive tract disorders
#4476STAT3 Agonists and Antagonists and Therapeutic Uses Thereof
#4477DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh
#4478PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS
#4479COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#4480Antibodies against a peptide epitope of apoliporotein B
#4481NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS
#4482Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases
#4483Methods of reducing inflammation and mucus hypersecretion
#4484Genes and polypeptides relating to prostate cancers
#4485INHIBITION OF EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2 AS A TREATMENT FOR CARDIAC HYPERTROPHY AND HEART FAILURE
#4486Methods and compositions for delivering interleukin-1 receptor antagonist
#4487Enhancing stem cell mobilization
#4488Conversion of apoptotic proteins
#4489Compositions and methods for inhibiting cell migration
#4490Use of BPI Protein for Treatment of Diseases
#4491VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT
#4492Compositions and methods for promoting wound healing and tissue regeneration
#4493Use of mutant Herpes Simplex Virus-2 for cancer therapy
#4494Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#4495EXTRACELLULAR TNF INHIBITORS FOR TREATING CNS DISORDERS
#4496Protein involved in cancer
#4497Use of complement inhibitors to treat ocular diseases
#4498GUS3 NEUROPEPTIDES FOR REGULATING HYPOTHALAMIC FUNCTION
#4499Cancer antigen peptide and the use thereof
#4500COMBINATION CHAPERONIN 10 AND BETA-INTERFERON THERAPY FOR MULTIPLE SCLEROSIS